Why This Large Cap Stock Is Down After Buying Stake In Competitor

Shares of pharma major Ipca Laboratories tanked on Wednesday after the company completed buying a stake in rival Unichem Laboratories.

What Happened: Ipca said it successfully completed the acquisition, valued at ₹945.35 crore at ₹402.25 per share, which is at a premium of around 1% to Unichem’s last close.

The company said it has already made an open offer to public shareholders of Unichem as it looks to acquire up to 26% of Unichem Laboratories at a price of ₹440 per share, totaling ₹605.44 crore.

Price Action: Ipca’s share price was down nearly 1.55% at ₹888.40 in the afternoon on Wednesday.

Meanwhile, Unichem’s share price was down 0.45% at ₹396.50 late in the session.

Read Next: PayU Sets Sights On $6B Valuation for India IPO: Report

Take Stock Of The Week Ahead

Get all the latest Share Market trends and news to set you up for the week ahead.

Congratulations!
You have successfully subscribed.
Posted In: EquitiesM&AWIIMMarketsIPCAUnichem Laboratories